Article Text

other Versions

PDF
Cardiac diphosphonate uptake
  1. Walter Noordzij1,
  2. Andor W J M Glaudemans1,
  3. Riemer H J A Slart1,
  4. Bouke P C Hazenberg2
  1. 1Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
  2. 2Department of Rheumatology & Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
  1. Correspondence to Walter Noordzij, Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Hanzeplein 1, PO Box 30.001, Groningen 9700 RB, The Netherlands; w.noordzij{at}umcg.nl

Statistics from Altmetric.com

Image challenge

An elderly patient was known with generalised osteoarthritis and destruction of the right hip. Six months before, this patient was admitted to a general hospital because of oedema and ventricular tachycardia. No coronary artery disease was found on coronary angiogram and the tachycardia was successfully converted to sinus rhythm. MRI 3 months later showed diffuse asymmetric hypertrophy of the right and LV walls, with diffuse subendocardial and midwall late gadolinium enhancement, and a diminished LVEF of 35%, indicating a restrictive cardiomyopathy.

At referral to our hospital, the only complaints were fatigue and dyspnoea when climbing the stairs. Physical examination showed no additional abnormalities. Serum analysis revealed elevated levels …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles